Sandy Zinke Presents Lumeda at LSI USA '23

Lumeda is developing DigiLum, a light dosimetry solution that utilizes artificial intelligence (AI) and photonics to activate a photosensitizer drug and deliver photodynamic therapy for the treatment of Non-Small Cell Lung Cancer (NSCLC).
Speakers
Sandy Zinke
Sandy Zinke
CEO, Lumeda